What is the current Cardiopulmonary Bypass System market size?

The Cardiopulmonary Bypass System market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Cardiopulmonary Bypass System market?

Key drivers include rising cardiovascular disease prevalence and advancements in medical technology, fueling future outlook.

What challenges does the Cardiopulmonary Bypass System market face?

Challenges include high equipment costs and stringent regulatory requirements, impacting market growth.

Which regions are the leaders in the Cardiopulmonary Bypass System market?

North America and Europe are regional leaders, with Asia-Pacific emerging as a significant market, driving market size.

Who are the top companies in the Cardiopulmonary Bypass System market?

Top companies include Medtronic, Getinge, and LivaNova, offering innovative solutions, shaping the future outlook.

What future opportunities exist in the Cardiopulmonary Bypass System market?

Future opportunities include emerging markets and technological advancements, such as minimally invasive procedures, impacting market size.

How will technology impact the Cardiopulmonary Bypass System market?

Technology will drive growth, with advancements in pump design and monitoring systems, enhancing patient outcomes, and fueling growth forecast.

What is the current regulatory landscape for the Cardiopulmonary Bypass System market?

The regulatory landscape is stringent, with FDA and CE mark approvals required, ensuring patient safety, and influencing market size.

Cardiopulmonary Bypass System Strategic Analysis & Growth Outlook 2033

Cardiopulmonary Bypass System by Application (Hospitals, Clinics, Ambulatory Surgical Centers), by Types (Conventional Cardiopulmonary Bypass System, Mini Cardiopulmonary Bypass System), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 3.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 3.7%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Cardiopulmonary Bypass System Market Size | CAGR 3.7 Forecast 2033

Cardiopulmonary Bypass System Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 3.7%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.9 million

CAGR: 3.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Cardiopulmonary Bypass System Market Overview

The Cardiopulmonary Bypass System market refers to the industry that provides medical devices and equipment used to temporarily take over the function of the heart and lungs during surgery, maintaining the circulation of blood and oxygenation of the body. As the global healthcare landscape continues to evolve, the Cardiopulmonary Bypass System market size is projected to experience significant growth, driven by an increasing demand for cardiovascular surgeries and advancements in medical technology. The growth outlook for the Cardiopulmonary Bypass System market is positive, with an estimated market size of $1.4 billion in 2025, and a market forecast that indicates a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2026 to 2033. The industry expansion is expected to be driven by macro drivers such as the rising prevalence of cardiovascular diseases, an aging population, and advancements in cardiopulmonary bypass technologies.

Loading chart…

The key forces shaping the Cardiopulmonary Bypass System industry include technology shifts towards more advanced and minimally invasive cardiopulmonary bypass systems, regulations such as those related to device safety and efficacy, and consumer behavior driven by increasing awareness of cardiovascular health. The largest region for the Cardiopulmonary Bypass System market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by increasing demand for cardiovascular surgeries and advancements in healthcare infrastructure. Overall, the Cardiopulmonary Bypass System market is expected to experience significant growth and industry expansion, driven by a combination of technological advancements, increasing demand, and macroeconomic drivers.

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	11.90 million
Growth rate	CAGR of 3.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sorin Group; Braile Biomedica; Transonic; Spectrum Medical; Minnetronix; Medtronic; MAQUET Holding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cardiopulmonary Bypass System market is experiencing significant growth, driven by various factors. The market dynamics are crucial in understanding the current and future trends in the Cardiopulmonary Bypass System market size and growth forecast.

Growth Drivers2 items

Advancements in technology, such as the development of portable and miniaturized cardiopulmonary bypass systems, are increasing their adoption in emergency and critical care settings

The rising prevalence of cardiovascular diseases and the growing need for cardiac surgeries are driving the demand for cardiopulmonary bypass systems, contributing to the growth of the Cardiopulmonary Bypass System market

Restraints2 items

The high cost of cardiopulmonary bypass systems and the need for specialized training for healthcare professionals are limiting their adoption in developing countries and small-sized hospitals

Stringent regulatory requirements and the need for frequent maintenance and upgrades are also restraining the growth of the Cardiopulmonary Bypass System market size

Opportunities2 items

The increasing demand for minimally invasive and robotic-assisted cardiac surgeries is creating opportunities for the development of new and innovative cardiopulmonary bypass systems, driving the growth forecast of the Cardiopulmonary Bypass System market

The growing trend of outpatient and ambulatory care services is also providing opportunities for the adoption of portable and compact cardiopulmonary bypass systems

Challenges2 items

The Cardiopulmonary Bypass System market is facing challenges due to the competitive landscape and the presence of established players, making it difficult for new entrants to gain market share

The need for continuous innovation and investment in research and development is also a challenge for manufacturers to stay competitive in the Cardiopulmonary Bypass System market and achieve a positive growth forecast

Market Segmentation

Loading chart…

The Application segment of the Cardiopulmonary Bypass System market is a crucial aspect of Cardiopulmonary Bypass System segmentation. This market can be divided into subtypes such as coronary artery bypass grafting, heart transplant, and valve repair. Each of these subtypes contributes significantly to the overall market size, with coronary artery bypass grafting holding the largest share due to the high prevalence of cardiovascular diseases. Understanding these application segments is essential for market players to tailor their strategies and develop targeted solutions.

The Types segment of the Cardiopulmonary Bypass System market refers to the different kinds of systems used in cardiopulmonary bypass procedures. This includes subtypes such as traditional cardiopulmonary bypass systems and minimally invasive cardiopulmonary bypass systems. The traditional systems are widely used due to their established presence in the market, while minimally invasive systems are gaining traction due to their benefits in reducing trauma and recovery time. Analyzing these types and their respective market shares is vital for understanding the market taxonomy and identifying areas of growth.

Cardiopulmonary Bypass System Segmentation Breakdown7 items

Application

Hospitals

Clinics

Ambulatory Surgical Centers

Types

Conventional Cardiopulmonary Bypass System

Mini Cardiopulmonary Bypass System

Regional Insights

Loading chart…

The Cardiopulmonary Bypass System market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, government policies supporting healthcare infrastructure development, and growing investments in the healthcare sector.

Key drivers for North America include high ecosystem maturity, established infrastructure, and growing demand for cardiopulmonary bypass systems. In Europe, drivers include favorable demographics, increasing prevalence of cardiovascular diseases, and stringent regulatory policies. Asia Pacific is driven by rapidly expanding healthcare infrastructure, growing middle-class population, and increasing awareness of cardiovascular diseases. Latin America and Middle East & Africa are expected to be driven by government initiatives to improve healthcare access and rising investments in medical technologies.

The regional forecast indicates that the Cardiopulmonary Bypass System market will experience significant growth in the coming years, with Asia Pacific expected to drive the market growth. The regional forecast suggests that the market will be shaped by factors such as adoption rates, policies and regulations, and investments in healthcare infrastructure.

Competitive Landscape

The Cardiopulmonary Bypass System market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Cardiopulmonary Bypass System competitive landscape is driven by the need for companies to differentiate themselves through innovative products and services. Key competitive levers include pricing strategies, distribution networks, and product innovation, with companies focusing on developing advanced technologies to stay ahead in the market.

Companies in the market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies are focusing on strategic initiatives such as regional expansion, innovation pipeline, and local manufacturing.

Sorin Group: regional expansion

Braile Biomedica: vertical integration

Transonic: premium pricing

Spectrum Medical: OEM tie-ups

Minnetronix: innovation pipeline

Medtronic: local manufacturing

Key Cardiopulmonary Bypass System Companies7 items

Sorin Group

Braile Biomedica

Transonic

Spectrum Medical

Minnetronix

Medtronic

MAQUET Holding

Market Ecosystem

The Cardiopulmonary Bypass System ecosystem spans upstream, midstream, and downstream activities, involving various participants that create and capture value. Upstream, technology providers and suppliers deliver critical components, while midstream integrators and manufacturers assemble and refine the systems. Downstream, channels and end users interact, influencing adoption and driving demand. Understanding this ecosystem is essential for conducting a thorough value chain analysis.

Raw material/component suppliers — provide essential parts

OEMs / manufacturers — design and assemble systems

System integrators / EPCs — integrate and configure systems

Distributors / channel partners — deliver systems to end users

Service providers / after-sales — offer maintenance and support

End users / buyers — purchase and utilize the systems

Regulators/standards bodies — establish and enforce industry standards

In the Cardiopulmonary Bypass System ecosystem, control points, such as regulatory approvals and standards, influence adoption rates. Dependency risks, including input constraints and component availability, can impact system delivery. Switching costs and interoperability requirements may also affect partnerships and system integration. As the ecosystem differs by region, with varying standards and regulations, participants must adapt to local requirements, navigating complex relationships and dependencies to ensure seamless value flow.

Recent Industry Insights

The Cardiopulmonary Bypass System industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading medical device manufacturers have focused on enhancing the efficiency and safety of cardiopulmonary bypass systems. Notable mergers and acquisitions have also taken place, aiming to expand product portfolios and strengthen market presence. Furthermore, several product and technology launches have been observed, introducing advanced features such as improved pump designs and enhanced oxygenation capabilities.

In addition to these developments, regulatory changes have influenced the Cardiopulmonary Bypass System market, with a greater emphasis on patient safety and device efficacy. A shift in consumer and enterprise trends has also been noted, with a growing preference for minimally invasive procedures and personalized medicine. Funding rounds and expansions have supported the growth of emerging players in the market, driving innovation and competition in the Cardiopulmonary Bypass System industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Cardiopulmonary Bypass System market outlook. The market attractiveness is moderate, driven by increasing demand for cardiac surgeries and advancements in medical technology. Competitive intensity is high, with key players competing for market share. The long-term outlook is positive, with growth opportunities in emerging markets and innovation in portable bypass systems. The innovation landscape is rapidly evolving, with a focus on miniaturization and artificial intelligence. Demand-supply balance is expected to be stable, with key risk factors including regulatory changes and supply chain disruptions.

12 items

1. Executive Summary

2. Cardiopulmonary Bypass System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cardiopulmonary Bypass System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Cardiopulmonary Bypass System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Cardiopulmonary Bypass System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Cardiopulmonary Bypass System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Cardiopulmonary Bypass System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Cardiopulmonary Bypass System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Cardiopulmonary Bypass System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Cardiopulmonary Bypass System Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Cardiopulmonary Bypass System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Cardiopulmonary Bypass System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cardiopulmonary Bypass System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cardiopulmonary Bypass System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Cardiopulmonary Bypass System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Cardiopulmonary Bypass System Market Competition by Key Manufacturers

9.1. Global Cardiopulmonary Bypass System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Cardiopulmonary Bypass System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sorin Group

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Braile Biomedica

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Transonic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Spectrum Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Minnetronix

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medtronic

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MAQUET Holding

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cardiopulmonary Bypass System Market

Figure 4: Global Cardiopulmonary Bypass System Market: Drivers

Figure 5: Global Cardiopulmonary Bypass System Market: Challenges

Figure 6: Global Cardiopulmonary Bypass System Market: Trends

Figure 7: Global Cardiopulmonary Bypass System Market: Opportunity

Figure 8: Global Cardiopulmonary Bypass System Market: Restraint

Figure 9: Global Cardiopulmonary Bypass System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Cardiopulmonary Bypass System Market Value (USD Million) By Region

Figure 19: Global Cardiopulmonary Bypass System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Cardiopulmonary Bypass System Market Value (USD Million) By Region

Figure 27: Global Cardiopulmonary Bypass System Market Share (%) By: Regions (2032)

Figure 28: Global Cardiopulmonary Bypass System Market Volume (K) By Region

Figure 29: Global Cardiopulmonary Bypass System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Cardiopulmonary Bypass System Market Value (USD Million) By Region

Figure 37: Global Cardiopulmonary Bypass System Market Share (%) By: Regions (2032)

Figure 38: Global Cardiopulmonary Bypass System Market Volume (K) By Region

Figure 39: Global Cardiopulmonary Bypass System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Cardiopulmonary Bypass System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cardiopulmonary Bypass System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cardiopulmonary Bypass System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Cardiopulmonary Bypass System Market Value (USD Million) By Region

Table 14: Global Cardiopulmonary Bypass System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Cardiopulmonary Bypass System Market Volume (K) By Region

Table 31: Global Cardiopulmonary Bypass System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Cardiopulmonary Bypass System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Cardiopulmonary Bypass System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Cardiopulmonary Bypass System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sorin Group Basic Information And Sales Area

Table 52: Sorin Group. Products Portfolio

Table 53: Braile Biomedica Basic Information And Sales Area

Table 54: Braile Biomedica. Products Portfolio

Table 55: Transonic Basic Information And Sales Area

Table 56: Transonic. Products Portfolio

Table 57: Spectrum Medical Basic Information And Sales Area

Table 58: Spectrum Medical. Products Portfolio

Table 59: Minnetronix Basic Information And Sales Area

Table 60: Minnetronix. Products Portfolio

Table 61: Medtronic Basic Information And Sales Area

Table 62: Medtronic. Products Portfolio

Table 63: MAQUET Holding Basic Information And Sales Area

Table 64: MAQUET Holding. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Cardiopulmonary Bypass System Market Value (USD Million) By Region

Table 74: Global Cardiopulmonary Bypass System Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Cardiopulmonary Bypass System Market Volume (K) By Region

Table 91: Global Cardiopulmonary Bypass System Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Cardiopulmonary Bypass System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.90 million
Revenue forecast in 2033	11.90 million
Growth rate	CAGR of 3.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sorin Group; Braile Biomedica; Transonic; Spectrum Medical; Minnetronix; Medtronic; MAQUET Holding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options